Magnetic resonance images can add valuable information to prenatal fetal assessment.
Magnetic resonance imaging is becoming an increasingly important tool in assessing prenatal disease, according to a presentation featured in an electronic exhibit at the American Roentgen Ray Society 2015 Annual Meeting (ARRS) in Toronto, Canada.
Researchers from the Mayo Clinic and Nemours Children’s Hospital in Jacksonville, Florida, reviewed a series of fetal MRI cases for assessment of fetal anatomy and pathology to highlight the diagnostic capability of fetal MRI. No gadolinium is used for the imaging, which is done typically after 18 to 20 weeks’ gestation.
As 3T MRI scanners become more common due to their improved image signal-to-noise ratio and anatomical detail, the benefits of 3T MRI must be weighed against potential risks to the fetus that may result from the higher field strength.
The imaging was performed at the researchers’ facility; sequences were monitored in real time by a radiologist at the scanner and manipulated to determine optimal imaging planes during the scan. T2-weighted HASTE (TR/TE, 1500/60; 4-mm slice thickness) sequences are obtained in the axial, coronal, and sagittal planes with respect to the fetus.
"MRI is playing an increasingly important role in the assessment of complex prenatal disease," co-author Kathleen E. Carey, MD, said in a release. "The use of stronger 3-T field strengths may allow for improved visualization of subcutaneous fat and osseous structures, including the hands and feet of the developing fetus."
The researchers concluded that although ultrasound is still the initial imaging study for prenatal assessment of the fetus, MR imaging is playing an increasingly important role in the assessment of complex prenatal disease. “It is important to be aware of the indications and limitations of fetal MRI at 1.5-T as well as higher field strengths as the diagnostic community continues to move in the direction of 3-T,” they wrote.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.